At the beginning of the two-hour segment, Dr. Kriteman discussed his background at Yale University and his experience working as an investment banker on Wall Street before heading to medical school.
However, for the majority of the interview, Dr. Kriteman explained how the common myth of benign prostatic hyperplasia being connected to prostate cancer is not true. He also examined the minimally invasive and surgical options for the treatment of benign prostatic hyperplasia, including transurethral resection of the prostate (TURP), greenlight, aqua ablation, and Urolift procedures.
Dr. Kriteman closed the segment emphasizing how medication doesn’t have to be the first option of patients suffering from BPH. He stated, “Once I have all of the information on my patient’s case, I can better guide the patient on what their options are. Then, it’s a shared decision between the patient and the surgeon to figure out what’s going to be the best way to achieve the restoration of confidence and health.”
Georgia Urology is pleased to announce a partnership with WSB’s sportscaster Chuck Dowdle, as an addition to our fall prostate cancer awareness campaign. Dowdle speaks on prostate cancer statistics and on the importance of prostate cancer screenings in the spots airing on WSB this fall. Check out the spot below, and look for them airing […]
The votes are in! Thank you for voting Georgia Urology as Best Urology 2015 in Best Self Atlanta Magazine’s “Best of 2015 Contest!” We love serving the Atlanta community and are honored to keep you at your best.
On Saturday, July 25, 2020, Georgia Urology’s newly named Chief Executive Officer, Dan Fellner, appeared on “Lenz on Business” on WSB Radio. Fellner brings nearly 25 years of law practice and human resources experience to the table. Formerly our Director of Human Resources, Fellner brings a unique perspective to his new position as the CEO. […]
